Fennec Pharmaceuticals Inc. – Transcripts

NASDAQ: FENC
Share price (5/22/26): $9.93
Market cap (5/22/26): $343 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Transcripts

All mentions

CY 2026

Earnings Revised 05/14/26 Fennec Pharmaceuticals Inc., Q1 2026 Earnings Call, May 14, 2026 05/14/26

Earnings Revised 03/24/26 Fennec Pharmaceuticals Inc., Q4 2025 Earnings Call, Mar 24, 2026 03/24/26

CY 2025

Earnings Revised 08/14/25 Fennec Pharmaceuticals Inc., Q2 2025 Earnings Call, Aug 14, 2025 08/14/25

Earnings Revised 05/13/25 Fennec Pharmaceuticals Inc., Q1 2025 Earnings Call, May 13, 2025 05/13/25

Earnings Revised 03/10/25 Fennec Pharmaceuticals Inc., Q4 2024 Earnings Call, Mar 10, 2025 03/10/25

CY 2024

Other Revised 12/16/24 Fennec Pharmaceuticals Inc. - Special Call 12/16/24

Earnings Revised 01/03/25 Fennec Pharmaceuticals Inc., Q3 2024 Earnings Call, Nov 07, 2024 11/07/24

Earnings Revised 08/13/24 Fennec Pharmaceuticals Inc., Q2 2024 Earnings Call, Aug 13, 2024 08/13/24

Earnings Revised 05/14/24 Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 05/14/24

Earnings Revised 05/28/24 Fennec Pharmaceuticals Inc., 2023 Earnings Call, Mar 21, 2024 03/21/24

CY 2023

Earnings Revised 11/06/23 Fennec Pharmaceuticals Inc., Q3 2023 Earnings Call, Nov 06, 2023 11/06/23

Earnings Revised 09/04/23 Fennec Pharmaceuticals Inc., Q2 2023 Earnings Call, Aug 03, 2023 08/03/23

Earnings Revised 05/11/23 Fennec Pharmaceuticals Inc., Q1 2023 Earnings Call, May 11, 2023 05/11/23

CY 2020

Other Revised 08/11/20 Fennec Pharmaceuticals Inc. - Special Call 08/11/20

Other Revised 06/22/20 Fennec Pharmaceuticals Inc. - Shareholder/Analyst Call 06/22/20